Literature DB >> 28585150

Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases.

Dan Sun1, Wen-Hong Chen2, Suraj Baralc3, Juan Wang4, Zhi-Sheng Liu1, Yuan-Peng Xia5, Lei Chen6.   

Abstract

Mild encephalopathy/encephalitis with a reversible splenial (MERS) lesion is a clinic-radiological entity. The clinical features of MERS in neonates are still not systemically reported. This paper presents five cases of MERS, and the up-to-date reviews of previously reported cases were collected and analyzed in the literature. Here we describe five cases clinically diagnosed with MERS. All of them were neonates and the average age was about 4 days. They were admitted for the common neurological symptoms such as hyperspasmia, poor reactivity and delirium. Auxiliary examinations during hospitalization also exhibited features in common. In this report, we reached following conclusions. Firstly, magnetic resonance imaging revealed solitary or comprehensive lesions in the splenium of corpus callosum, some of them extending to almost the whole corpus callosum. The lesions showed low intensity signal on T1-weighted images, homogeneously hyperintense signal on T2-weighted images, fluid-attenuated inversion recovery and diffusion-weighted images, and exhibited an obvious reduced diffusion on apparent diffusion coefficient map. Moreover, the lesions in the magnetic resonance imaging disappeared very quickly even prior to the clinical recovery. Secondly, all the cases depicted here suffered electrolyte disturbances especially hyponatremia which could be easily corrected. Lastly, all of the cases recovered quickly over one week to one month and majority of them exhibited signs of infections and normal electroencephalography.

Entities:  

Keywords:  magnetic resonance imaging; mild encephalopathy/encephalitis with a reversible splenial lesion; neonate

Mesh:

Substances:

Year:  2017        PMID: 28585150     DOI: 10.1007/s11596-017-1753-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Kawasaki disease-associated MERS: pathological insights from SPECT findings.

Authors:  Tatsuharu Sato; Yoko Ushiroda; Toshifumi Oyama; Akiko Nakatomi; Hideki Motomura; Hiroyuki Moriuchi
Journal:  Brain Dev       Date:  2011-10-22       Impact factor: 1.961

2.  Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Rie Miyata; Naoyuki Tanuma; Masaharu Hayashi; Takuji Imamura; Jun-ichi Takanashi; Rieko Nagata; Akihisa Okumura; Hirohumi Kashii; Sunao Tomita; Satoko Kumada; Masaya Kubota
Journal:  Brain Dev       Date:  2011-05-14       Impact factor: 1.961

3.  Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Jun-ichi Takanashi; Atsushi Imamura; Fumio Hayakawa; Hitoshi Terada
Journal:  J Neurol Sci       Date:  2010-03-16       Impact factor: 3.181

4.  Clinico-radiological spectrum of reversible splenial lesions in children.

Authors:  Mitsuru Kashiwagi; Takuya Tanabe; Shuichi Shimakawa; Michiko Nakamura; Shinya Murata; Kousuke Shabana; Jun Shinohara; Yutaka Odanaka; Hideki Matsumura; Koh Maki; Kenichi Okumura; Keisuke Okasora; Hiroshi Tamai
Journal:  Brain Dev       Date:  2013-06-20       Impact factor: 1.961

Review 5.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.

Authors:  H Tada; J Takanashi; A J Barkovich; H Oba; M Maeda; H Tsukahara; M Suzuki; T Yamamoto; T Shimono; T Ichiyama; T Taoka; O Sohma; H Yoshikawa; Y Kohno
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible: A case report.

Authors:  Yuji Hashimoto; Jun-ichi Takanashi; Keiko Kaiho; Katsunori Fujii; Toshiyuki Okubo; Setsuo Ota; Yoichi Kohno
Journal:  Brain Dev       Date:  2008-11-28       Impact factor: 1.961

Review 7.  Reversible splenial lesion syndrome (RESLES): what's in a name?

Authors:  Juan Carlos Garcia-Monco; Ines Escalza Cortina; Eva Ferreira; Amaia Martínez; Lara Ruiz; Alberto Cabrera; Marian Gomez Beldarrain
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

Review 8.  [Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child and literature review].

Authors:  Lirong Zhao; Ye Wu; Mangmang Guo; Jiangxi Xiao; Yuwu Jiang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2014-03

Review 9.  Two newly proposed infectious encephalitis/encephalopathy syndromes.

Authors:  Jun-ichi Takanashi
Journal:  Brain Dev       Date:  2009-03-31       Impact factor: 1.961

  9 in total
  4 in total

1.  A Neonatal Case of Mild Encephalopathy/Encephalitis with a Reversible Splenial Lesion.

Authors:  Yuzuki Oki; Tomohide Yoshida; Akira Yogi; Shingo Kurokawa; Hideki Goya; Mayumi Tsukayama; Sadao Nakamura; Keiko Mekaru; Koichi Nakanishi
Journal:  Child Neurol Open       Date:  2022-08-01

2.  Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.

Authors:  Qing Yang; Can-Can Chang; Mengxiao Liu; Yong-Qiang Yu
Journal:  BMC Med Imaging       Date:  2019-04-30       Impact factor: 1.930

Review 3.  Reversible lesion in the splenium of the corpus callosum.

Authors:  Syuichi Tetsuka
Journal:  Brain Behav       Date:  2019-10-06       Impact factor: 2.708

4.  Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.

Authors:  Xinying Zhang; Na Chen; Jiamin Guo; Shuwei Li; Jiaming Xu; Weiwei Zhu; Aihua Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.